Introduction
Short chain fatty acids (SCFAs) are saturated fatty acids characterized by an aliphatic carbon chain length of at most eight carbon atoms [1] , which are mainly produced in a fermentation process by microbiota in the colon and the distal small intestine from resistant starch or dietary fiber [2, 3] . Acetate, propionate, and butyrate ( Fig. 1A) are the predominant SCFAs in the proximal regions of the large intestine in humans and rodents, and are present at high mM levels [3] [4] [5] [6] [7] . Once produced, SCFAs are readily absorbed by enterocytes of the intestines [8] . It has been reported that the majority of absorbed SCFAs are used as an energy source, but a portion of these absorbed fatty acids is released via the basolateral membrane to the hepatic portal vein and then reaches the systemic circulation. After reaching systemic circulation, low concentration SCFAs will affect the biological activities of various peripheral tissues [9, 10] . There is evidence that SCFAs are able to have anti-inflammatory effects on the digestion system and other tissues to attenuate the development of related inflammatory diseases including inflammatory bowel disease (IBD), colon cancer, obesity and type 1 and 2 diabetes mellitus [11] [12] [13] [14] [15] . However, the effects of SCFAs on various cardiovascular diseases associated with inflammation remain poorly understood.
The Nlrp3 inflammasome, an intracellular inflammatory machinery, is a well-characterized type of inflammasome in mammalian cells so far. It consists of a large cytosolic multiprotein complex formed mainly by the sensor protein, Nod-like receptor pyrin domain 3 (Nlrp3), the adaptor protein apoptosis-associated speck-like protein (Asc), and the pro-inflammatory caspase-1 [16] [17] [18] [19] . Upon pathological stimulations, Nlrp3 inflammasome components are assembled leading to the autocatalysis and activation of caspase-1, which is responsible for the maturation of pro-inflammatory cytokines, such as bioactive interleukin-1β (IL-1β) and interleukin-18 (IL-18) [20, 21] . The Nlrp3 inflammasome has been implicated in the pathogenesis of various metabolic diseases including diabetes mellitus, gout, silicosis, acute myocardial infarction, T and liver toxicity [17, 20, 22, 23] . With respect to the effects of SCFAs, Wang et al. reported that the Nlrp3 inflammasome was activated by sodium butyrate in db/db mice [24] , while Ho et al. demonstrated that bamboo vinegar decreases inflammatory mediator expression and Nlrp3 inflammasome activation by inhibiting reactive oxygen species (ROS) generation and protein kinase C-α/δ activation both in vitro and in vivo [25] . There is evidence that ketone bodies, β-hydroxybutyrate (BHB), but not acetoacetate (AcAc) or the structurally related SCFAs, butyrate and acetate, suppress activation of the Nlrp3 inflammasome in response to urate crystals, ATP and lipotoxic fatty acids [25, 26] . All these studies have suggested that SCFAs may target Nlrp3 inflammasome formation and activation to produce corresponding biological action. Since activation of the Nlrp3 inflammasome has been reported to be involved in coronary endothelial dysfunction and atherosclerosis [27] , we hypothesized that the endothelial Nlrp3 inflammasome may be a target for SCFAs to alter endothelial function and neointima formation.
In the present study, we used partial carotid ligation (PLCA) as a model of acutely induced disturbed flow leading to rapid endothelial dysfunction and atherosclerosis [28] . This model is considered as an appropriate animal model for studying endothelial injury associated with inflammatory response such as macrophage infiltration, smooth muscle proliferation, and extracellular matrix reorganization and resulting remodeling of LCA with intima-media-adventitial thickening (IMT) [29] . In recent studies, our laboratory also showed that PLCA is an ideal model for studies on the formation and activation of Nlrp3 inflammasomes, which consequently lead to arterial inflammation and endothelial dysfunction in mice. As one component of Nlrp3 inflammasome, Asc expression increased in the neointima after vascular injury in mice [30] , and Nlrp3 inflammasome formation and activation were blocked in Asc knock-out mice [31] . Therefore, the present study tested the effects of SCFAs on Nlrp3 inflammasomes using PLCA-induced neointeima formation model with wild type mice (Asc +/+ ) and Asc knock-out mice (Asc -/-), where Asc -/was considered as a positive control for confirmation of Asc associated inflammasome is involved in the effects of SCFAs.
The present study was designed to analyze the effects of SCFAs (acetate, propionate and butyrate) on Nlrp3 inflammasome formation and activation in endothelial cells. We first examined whether SCFAs had inhibitory effects on Nlrp3 inflammasome formation and activation in vivo using a partially ligated carotid artery (PLCA) model in wild type mice on the Western diet (WD) [16] , which was compared with the effects of Asc gene knockout (Asc -/-) mice. Then, we further explored the mechanisms by which SCFAs alter Nlrp3 inflammasomes upon stimulations of atherosclerotic stimuli such as 7-ketocholesterol (7-Ket) and cholesterol crystals (CHC). Our results demonstrated that different SCFAs had differential effects on the Nlrp3 activation and arterial neointima formation. Among SCFAs, butyrate was shown to have a promising beneficial effect, which can be exploited as a new source for the development of therapeutic strategies for atherosclerotic diseases.
Materials and methods

Mice
All animal experiments were performed in accordance with the National Institutes of Health guidelines for the care and use of laboratory animals. The protocols were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University. Eightweek-old male and female C57BL/6J Asc wild-type (Asc +/+ ) and Asc knock-out (Asc -/-) mice were used in the current study. Mice were maintained in a controlled environment of 20°C and 40-50% humidity, with a 12-h light/dark cycle. Asc +/+ and Asc -/mice were separated into 4 groups randomly and fed with the WD for 30 days.
Partial ligated carotid artery
Partial ligated carotid artery (PLCA) surgery was performed as previously reported by others [29, [32] [33] [34] [35] . Briefly, mice were anaesthetized with 2% isoflurane inhalation for 5 min and epilated in the neck, then continued being anaesthetized through a nose cone. A ventral midline incision was made in the neck disinfected with 70% ethanol, and then the muscle layers were separated with curved forceps to expose the left carotid artery after blunt dissection. The external carotid, internal carotid and occipital artery were ligated with a piece of 6.0 silk suture, while the superior thyroid artery was left intact, which provided the sole source for blood circulation. The right carotid artery was not ligated and served as an internal control. After closing the incision and disinfection, the mice were kept on a heating pad until they gained consciousness. Two days before PLCA, mice were injected intraperitoneally with 500 mg/kg acetate sodium, propionate sodium or butyrate sodium once a day for 17 days. The dose of these SCFAs chosen to be used in these animal protocol were based on our preliminary studies in cells, which was calculated from a concentration mostly effective in vitro into in vivo doses (see Figs. S1-S3 in Supplementary material). These doses of SCFAs used were also consistent from some previous studies [36, 37] . After two weeks of PLCA, mice were sacrificed and both of their carotid arteries were perfused and isolated for frozen sections and paraffin sections. The slides were used for immunohistochemistry, dual fluorescence staining and confocal analysis respectively.
Immunofluorescence staining
Cells cultured in 8-well plates or coronary artery on frozen slides were rinsed 2-3 times for 5 min with PBS and fixed in 4% paraformaldehyde in PBS for 15 min. After being washed 2-3 times with PBS for 5 min, the samples were permeabilizated with 0.1% Triton X-100 in PBS for 10 min and were washed 2-3 times for 5 min with PBS. Then samples were incubated with a primary antibody overnight at 4°C followed by incubation with either Alexa-488-or Alexa-555-labeled secondary antibody for 1 h at room temperature in the dark room. Finally, the slides were mounted with mounting medium with DAPI and sealed with nail polish for taking pictures using a confocal laser scanning microscope (Fluoview FV1000; Olympus, Tokyo, Japan). Cell or tissue specific staining intensity was measured and analyzed with Image J software. The colocalization of Nlrp3 with Asc or caspase-1 was analyzed by the Image Pro Plus version 6.0 software (Media Cybernetics, Bethesda, MD). These summarized colocalization efficiency data were expressed as Pearson correlation coefficient (PCC) as described previously [32, 38] .
Immunohistochemistry
The carotid arteries were embedded with paraffin and 5 µm slices were cut from the embedded blocks. After heat-induced antigen retrieval, slides were incubated with primary antibodies diluted in phosphate-buffered saline (PBS). Anti-IL-1β antibodies were used in this study. After incubation with primary antibody overnight, the sections were washed in PBS and incubated with biotinylated IgG (1:250) for 1 h and then with streptavidin-HRP for 30 min at room temperature. Then, 50 μl of DAB was added to each section and stained for 1-5 min. After washing, the slides were counterstained with hematoxylin for 2 min. The slides were then mounted and observed under a microscope in which photos were taken [39] .
In situ analysis of caspase-1 activity
Caspase-1 activity was performed as we described previously [19] . This assay used Fluorescent Labeled Inhibitor of Caspases (FLICATM) probes (ImmunoChemistry Technologies, LLC, Bloomington, MN, USA) to label activated caspase-1 enzyme in the coronary arterial endothelium. The FLICA probes are comprised of a caspase-1 recognition sequence tyrosine-valine-alanine-aspartic acid (YVAD) that binds to active caspase-1, a fluoromethyl ketone (FMK) moiety that results in irreversible binding with the enzyme, and a fluorescent tag FAM (carboxyfluorescein) reporter. After entering the cells, the FLICA reagent FAM-YVAD-FMK becomes covalently coupled to the active caspase-1, while any unbound FLICA reagent diffuses out of the cell and is washed away. The remaining green fluorescent signal is a direct measure of the active caspase-1 enzyme activity in the cell or tissue samples. To detect caspase-1 activity in the coronary arterial endothelium, frozen artery section slides were first fixed in acetone and incubated overnight at 4°C with sheep anti-vWF (1:200; Abcam). These slides were then co-stained with fluorescence conjugated anti-sheep secondary antibody and FLICA reagent (1:10) from a FLICATM Caspase 1 Assay Kit (Immunochemistry Technologies, LLC) for 1.5 h. at room temperature, washed, mounted, visualized and analyzed by confocal microscopy as described above. Colocalization was analyzed by Image Pro Plus software. The colocalization coefficient was represented by PCC.
Cell culture
The mouse EC cell line also known as EOMA cells was purchased from ATCC, which isolated originally from mouse hemangioendothelioma. Passage 5-10 EOMA cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco), supplemented with 10% FBS (Gibco) and 1% penicillin-streptomycin (Gibco) in humidified 100% air and 5% CO 2 mixture at 37°C. 2 × 10 5 cells were prepared in 6-well plates overnight, 80-90% confluence cells were treated with 5 mM acetate sodium, 5 mM propionate sodium or 1 mM butyrate sodium for 2 h before being treated with or without 7-Ket or CHC for 24 h as described previously [27] .
Western blot analysis
Western blot analysis was performed as we described previously [40] . Briefly, total protein was extracted using lysis buffer with protein inhibitor after being washed in cold PBS. Protein concentrations were measured and resuspended to 2 μg/μl. Cell lysates were run on a SDS-PAGE gel at a voltage of 100 V for 2 h, transferred into polyvinylidene difluoride membrane at voltage of 100 V for 1 h, and blocked with 5% non-fat milk in TBST buffer for 30 min. Then, the membrane was incubated with primary antibodies against, pro-caspase-1, or cleaved caspase-1 (1:500 dilution, Santa Cruz) overnight at 4°C, followed by incubation with a secondary antibody labeled with HRP for 1 h at room temperature. The membrane was developed with Kodak Omat film after being washed 3 times with TBST. β-actin (1:8000 dilution, Santa Cruz) was reported to serve as a loading control. The intensity of the bands was quantified using ImageJ 6.0 (NIH, Bethesda, MD, USA) [41] .
ELISA analysis of IL-1β secretions
The culture medium was collected for IL-1β quantification with an IL-1β ELISA kit according to the manufacturer's instructions and our previous studies [42] . In brief, 100 μl of the culture medium were added to a microplate strip well and incubated for 2 h at room temperature. Then, the solution was mixed with IL-1β conjugate and incubated for another 2 h at room temperature. Thorough washes were performed between and after the two incubations. 100 μl of substrate solution was applied to generate chemiluminescence. Chemiluminescent absorbance was determined using a microplate reader at λ = 450, corrected to readings at λ = 570. The IL-1β level was quantified by relating the sample readings to the generated standard curve. •to form ethidium bromide. It has been commonly used to detect cytosolic superoxide [44] . Upon its reaction with the superoxide anion, DHE forms a red fluorescent product, 2-hydroxyethidium [45] , with maximum excitation and emission peaks at 500 and 580 nm, respectively. In brief, the unfixed cells from different groups were incubated with DHE (10 μM) in phosphate-buffered saline at room temperature for 30 min. Then, the slides were washed, fixed, mounted, and subjected to confocal microscopic analysis (Fluoview FV1000; Olympus).
Statistics
Data are presented as means ± SEM. Significant differences between and within multiple groups were examined using ANOVA for repeated measures, followed by Duncan's multiple-range test. The statistical analysis was performed by Sigmaplot 12.5 software (Systat Software, San Jose, CA, USA). P < 0.05 was considered statistically significant.
Results
Effects of SCFAs on the formation of Nlrp3 inflammasomes in the arterial wall of PLCA
We first performed in vivo animal experiments to determine whether SCFAs prevent or enhance inflammasome activation and vascular injury using a mouse model with partial ligated carotid artery. Using confocal microscopy, the co-localization of Nlrp3 vs. Asc or caspase-1, as shown in yellow color in the arterial, increased in PLCA in wild type mice, which was seen in contralateral carotid artery (not shown). This suggests the formation of Nlrp3 inflammasomes on the wall of PLCA. However, this increased Nlrp3 inflammasome formation (colocalization of its components) was not seen in the wall of PLCA of Asc -/mice ( Figs. 1B and 1C) . Surprisingly, we found that both acetate and propionate markedly increased the formation of this Nlrp3 inflammasome in PLCA wall of Asc +/+ mice, but they had no effect in Asc -/mice. However, butyrate almost completely blocked the formation of NRLP3 inflammsomes in PLCA wall of Asc +/+ , which was similar to that observed in Asc -/mice. These results were summarized in Figs. 1C and 1E, and they suggest that administration of acetate or propionate promote vascular injury in the PLCA model, but butyrate has protective effects on vascular injury in the same mouse model.
Effects of SCFAs on endothelial caspase-1 activity and IL-1β production in the arterial wall of PLCA
Corresponding to the effects of SCFAs on Nlrp3 inflammasome formation, caspase-1 activation as shown by FLICA positive staining was found in the endothelium of PLCA, acetate, and propionate markedly increased active caspase-1 levels. However, butyrate blocked endothelial caspase-1 activation in PLCA. In Asc -/mice, PLCA did not exhibit any endothelial activation of NRLP3 inflamamsomes, and the three SCFAs had no effects on caspase-1 activation in PLCA ( Figs. 2A  and 2B ). We also examined IL-1β production in the wall of PLCA in Asc +/+ and Asc -/mice. As shown in Fig. 3 , it is clear that PLCA significantly increased IL-1β levels in the wall of PLCA of Asc +/+ mice, which was enhanced by either acetate or propionate treatment. However, butyrate treated Asc +/+ mice didn't show increased IL-1β production in the wall of PLCA. These alterations of IL-1β production in the wall of PLCA in Asc +/+ mice could not be observed in Asc -/mice, suggesting that arterial IL-1β production in PLCA is attributed to Ascdependent Nlrp3 inflammasome activation.
Effects of SCFAs on the neointima formation in PLCA
The neointima formation as a major pathological change in PLCA was also analyzed in Asc +/+ and Asc -/mice. It was found that administration of acetate or propionate caused a significant increase in the neointima formation in PLCA of Asc +/+ mice as compared to vehicle-treated Asc +/+ mice. In butyrate-treated Asc +/+ mice, however, the neointima formation in PLCA was significantly inhibited. This neointima formation in PLCA and the enhancing effects by acetate and propionate were not observed in Asc -/mice (Fig. 4A) . The quantitation of a ratio of intima vs. media is summarized in Fig. 4B . It is clear that acetate and propionate significantly enhanced the ratio of intima vs. media in PLCA, which is dependent upon the activation of inflammasome because their effects were not seen in Asc -/mice. However, butyrate had no effect on the ratio of intima vs. media in PLCA in both Asc +/+ and Asc -/mice.
Effects of SCFAs on the formation of Nlrp3 inflammasome in cultured ECs stimulated by 7-Ket and CHC
To explore the potential mechanisms mediating the effects of SCFAs specifically in ECs, we first examined the effects of 7-Ket and CHC on Nlrp3 inflammasome complex formation as shown by colocalization of Nlrp3 with Asc or caspase-1 in cultured ECs, which indicate the assembling of Nlrp3 inflammasome components (Figs. 5A and C). It was found that both 7-Ket and CHC significantly increased this inflammasome formation as compared to vehicle treated cells. Treatment of the cells with acetate not only significantly enhanced the Nlrp3 inflammasome (Nlrp3/Asc) formation stimulated by 7-Ket or CHC-stimulation, but also itself activated this inflammasome assembling. Propionate treatment only led to a significant decrease in Nlrp3 inflammasome formation in these cells with CHC stimulation, but not in those with 7-Ket as a proatherogenic stimulus. Interestingly, butyrate treatment had the opposite effect of acetate and propionate, which significantly inhibited Nlrp3 inflammasome formation stimulated by either 7-Ket or CHC. The colocalization of Nlrp3 with Asc or caspase-1 was summarized in Figs. 5B and D, which indicates the differential effects of the three SCFAs on the Nlrp3 inflammasome formation upon 
7-Ket and CHC in ECs.
Effects of SCFAs on the activation of Nlrp3 inflammasome induced by 7-Ket and CHC in ECs
We also examined the effects of SCFAs on the activation of Nlrp3 inflammasomes. It was found that the level of cleaved caspase-1 in ECs, which is reported as a parameter of Nlrp3 inflammasome activation in a variety of cell types, was significantly increased as shown by enhanced production of cleaved caspase-1 as compared to vehicle-treated cells. Acetate significantly increased cleaved caspase-1 levels and augmented 7-Ket-stimulated elevation of this cleaved caspase-1 in ECs. However, propionate had no effects on 7-Ket-stimulated increase in caspase-1 levels, while butyrate even reduced this 7-Ket-stimulated activation of caspase-1 (Figs. 6A and B) . In CHC stimulated cells, the three SCFAs had similar action patterns to those observed in 7-Ket-stimulated cells except propionate blocked CHC-induced increase in cleaved caspase-1 level (Figs. 6C and D) .
By quantitation of IL-1β production and direct analysis of caspase-1 activity, we further confirmed the effects of SCFAs on the activation of Nlrp3 inflammasome in ECs. As shown in Fig. 7A , acetate was found to significantly increase IL-1β production in the supernatant of cultured ECs and to enhance 7-Ket-and CHC-stimulated production of IL-1β. Propionate had no effects on 7-Ket-stimulated production of IL-1β, but inhibited CHC-stimulated increase in IL-1β production. Butyrate almost completely abolished both 7-Ket and CHC-stimulated production of IL-1β in these ECs. Fig. 7B shows the effects of the three different SCFAs on the caspase-1 activity in ECs with or without 7-Ket or CHC stimulations. Similar to quantitation of IL-1β, acetate significantly increased caspase-1 activity and enhanced 7-Ket-and CHC-stimulated activation of this enzyme activity. Propionate had no effects on 7-Ket-increased caspase-1 activity, but inhibited CHC-enhanced caspase-1 activity. Butyrate was found to completely block both 7-Ket and CHC-induced enhancement of caspase-1 activity.
Effects of butyrate associated with suppression of lipid raft redox signaling platform activation
Given previous reports about the beneficial action of SCFAs in a number of cardiovascular diseases, we were particularly interested in the mechanisms mediating the inhibitory effects of butyrate on Nlrp3 inflammasome formation and activation. Since recent studies showed that the lipid raft (LR) redox signaling platforms were involved in Nlrp3 inflammasome activation [46, 47] , we determined the contribution of LR redox signaling platform formation and activation induced by 7-Ket and CHC. In these experiments, ECs were stained with Alexa Fluor 488labeled CTXB (a LR marker) and anti-gp91 or anti-p47 antibody [NOX subunits] to detect clustering of LRs with both NOX subunits, an indicator of LR redox signaling platform formation or activation. It was found that butyrate prevented the increases in LR clustering with gp91 ( Fig. 8A and B) or p47 ( Fig. 8C and D) upon stimulations of 7-Ket or CHC, as shown by the yellow patch formation on the ECs membrane detected by confocal microscopy. This effect of butyrate was similar to that produced by a ROS scavenger, N-acetyl-L-cysteine (NAC, at 10 μM, Sigma) ( Fig. 8A-D) . We also performed ESR spectromentry and DHE staining to measure O 2
•production. It was found that 7-Ket or CHCinduced O 2 •production in ECs was blocked by butyrate, which was similar to the effect of NAC in the same cell preparations with 7-Ket or CHC stimulations ( Fig. 8E and F) .
Discussion
The development of cardiovascular diseases is often attributable to the early loss of endothelial functions caused by imbalances in lipid and glucose metabolism and by other danger factors such as cytokines, chemokines and damage-associated molecular patterns (DAMPs) [48] . The cellular or plasma lipid imbalances can result in a low-grade nonsterile inflammatory state of the affected endothelium, causing macrophage foam cell formation and fat-rich lipoproteins to accumulate in the subendothelial space and ultimately resulting in arterial sclerosis and plaque formation. Recently, we and others have reported that endothelial Nlrp3 inflammasome activation may be an important triggering mechanism by which endothelial injury in response to atherogenic stimuli activates vascular inflammation and also induces uncanonical detrimental effects on the endothelium itself and other cells leading to atherosclerosis [19, 27, 32, 49] . It has been indicated that the Nlrp3 inflammasome may be an important therapeutic target for treatment and prevention of atherosclerosis. The present study tested the potential effects of SCFAs on endothelial Nlrp3 inflammasome activation upon stimulation of atherogenic stimuli such as 7-Ket and CHC because these fatty acids were reported to possibly mediate the beneficial action of the diet with high fibers on cardiovascular diseases [10, [50] [51] [52] . We surprisingly found that among the three common SCFAs only butyrate inhibited endothelial NRLP3 inflammasome activation in ECs and prevented the arterial neointima formation in the PLCA model of mice. Acetate and propionate had minimal inhibitory effects on Nlrp3 inflammasome activation and even enhanced the arterial neointima formation in the PLCA model.
We first performed in vivo experiments to test the effects of SCFAs on carotid arterial injury using a mouse model with PLCA. In this model, partial ligation of the carotid artery stimulated vascular inflammation and marked neointima formation [53] . We recently demonstrated that the Nlrp3 inflammasome is importantly involved in the pathological process of the carotid artery in this PLCA mouse model [31] . Our results showed that among three SCFAs, only butyrate significantly decreased Nlrp3 inflammasome formation and activation in the endothelium of ligated carotid arteries in wild type mice, which was comparable to the reduction of Nlrp3 inflammasome activation when the mouse Asc gene was deleted. Correspondingly, butyrate significantly abolished the formation of neointima in partially ligated carotid arteries of mice. However, administration of acetate or propionate to mice markedly enhanced the formation and activation of Nlrp3 inflammasome in the carotid arteries with PLCA in Asc +/+ , but not Asc -/mice. This Nlrp3 inflammasome activation in wild type mice was accompanied by increased carotid neointima formation during PLCA.
As discussed above, some reported beneficial effects of SCFAs against the development of cardiovascular disease are mainly related to their anti-inflammatory actions, which were observed in different animal models. For example, Wang et al. reported that sodium butyrate treatment can efficiently inhibit Nlrp3 inflammasome activation and thereby inhibits obesity-induced inflammation, indicating that NaB might be a potential anti-inflammatory agent for obesity in db/db mice [24] . In Ldlr -/mice fed on high-cholesterol diet with Nlrp3-deficient or with Asc-deficient bone marrow transplantation, plasma levels of inflammatory cytokines such as IL-18 and IL-1 significantly decreased and atherosclerosis induced by high cholesterol was ameliorated [54] . These anti-inflammatory effects of butyrate were also observed in other animal models of vascular inflammation or atherosclerosis such as mice fed the WD, the mouse models of Nlrp3-mediated diseases like Muckle-Wells syndrome, familial cold auto-inflammatory syndrome and urate crystal-induced peritonitis as well as the DSS-induced colitis mouse model [55] . In addition to reduction of inflammatory cytokine production or release, butyrate and other SCFAs were also reported to increase the production of prostaglandin E 2 (PGE 2 ), an anti-inflammatory prostanoid [56] . Despite these anti-inflammatory effects, SCFAs were also demonstrated to have pro-inflammatory action in some conditions [57] . Several reports have also indicated that SCFAs promote ROS production leading to local tissue oxidative stress enhancing inflammatory response [14, 58, 59] . The present study demonstrates that the molecular mechanisms by which some SCFAs enhance the innate immune reaction or inflammatory response are due to activation of the intracellular inflammatory machinery, the inflammasome. In tissues with multiple cell types such as the vascular wall, SCFAs may have divergent effects on different cell types, with pro-inflammatory effects on some cell types like macrophages and microglial cells or with anti-inflammatory effects on other cell types such as the inhibitory action of butyrate on ECs [60] [61] [62] .
Although the present study did not focus on vascular smooth muscle cells (VSMCs), it is well known that both physical and biochemical interactions between ECs and VSMC play a crucial role in vascular homeostasis. ECs may exert regulatory action on VSMC to induce changes in their contractile phenotypes, and in arterial remodeling the interactions of VSMCs with resident vascular cells, extracellular matrix components, and circulating and infiltrating cells are important in the development of neointima and atherosclerotic plaques. Our previous studies have shown that neointima was inititated by endothelial inflammasome activation, which include VSMCs proliferation, extracellular matrix disturbance, and fibrogenesis [63, 64] . It is well known that VCMC phenotypic switch from contractile/differentiated to synthetic/dedifferentiated is essential in the pathogenesis of neointima formation [65] . SCFAs may alter these vascular pathologies during neointima formation via both inflammatory and uncanonical effects of the Nlrp3 inflammasome activation [27, 31, 66] .
To further confirm the effects of SCFAs specifically on ECs and explore related mechanisms, we also performed in vitro experiments in cultured ECs. We first examined the effects of SCFAs on Nlrp3 inflammasome activation induced by 7-Ket and CHC that act directly on the formation and activation of Nlrp3 inflammasomes in ECs. The use of 7-Ket and CHC as atherogenic stimuli is based on previous studies that demonstrated activation of this inflammasome in ECs (EOMA) through different mechanisms [67, 68] . It has been reported that 7-Ket as a soluble atherogenic stimulus may activate the Nlrp3 inflammasome through the redox signaling pathway, while CHC activates this inflammasome via crystal particle intrusion or membrane permeability changes to frustrate lysosomes and release cathpsin B [69] . We observed that butyrate significantly decreased the formation and activation of Nlrp3 inflammasomes induced by both 7-Ket and CHC, while propionate only blocked CHC-induced Nlrp3 inflammasome activation. However, acetate had no significant inhibitory effects on Nlrp3 inflammasome activation induced by either 7-Ket or CHC, but itself even activated Nlrp3 inflammsomes in these ECs. Although the present study represents the first study regarding the effects of SCFAs on endothelial Nlrp3 inflammasome activation, the inhibition of Nlrp3 inflammasome activation by butyrate and propionate is consistent with previous findings about the anti-inflammatory action of butyrate and propionate in vascular cells. In this regard, Zapolska-Downar et al. demonstrated that anti-inflammatory and (perhaps) antiatherogenic properties of butyrate may be partially attributed to an effect on the activation of NF-kappaB and PPARα and to associated expression of vascular cell adhesion molecule-1 (VCAM-1) and intracellular cell adhesion molecule-1 (ICAM-1) [70] . Fukae et al. also reported that butyrate may suppress the production of inflammatory mediators by monocytes and macrophages [71] . In human colonic subepithelial myofibroblasts, IFN-γ-induced IP-10 (inducible protein-10) secretion as a type of immune or inflammatory response was also not affected by acetate or propionate, but it was significantly reduced by butyrate [72] . In other studies, propionate and butyrate were found to inhibit the expression of proinflammatory mediators (TNF-α, CINC-2αβ and NO) in rat neutrophils, but acetate had no effect [73] . Butyrate and propionate, but not acetate may inhibit the expression of lipopolysaccharide (LPS)-induced production of inflammatory cytokines including neutrophil chemoattractant [55, 74, 75] .
In previous studies, peripheral concentrations of acetate, propionate, and butyrate were detected, which are 19-146, 1-13, and 1-12 µmol/L, respectively [76] . There is a general recognition that acetate is a predominant SCFAs in the blood. Recent studies have investigated its action on cardiovascular diseases, however, little is known about the effects of this SCFA on vascular inflammation. Some studies have indicated that acetate may have pro-inflammatory action, which might be due to its toxicity, rather than its pharmacological or therapeutic effect. The present study showed that acetate even at 100 mM had no toxic effects on cell survival, proliferation or growth (data not show), but it activated Nlrp3 inflammasomes. Similar studies reported that acetic acid in bamboo vinegar was not involved in its antiinflammatory activity and had no effects on vinegar-induced amelioration of Nlrp3 inflammasome-mediated IL-β increases in LPS-and ATP-activated macrophages [25] . Taken together, it is suggested that only butyrate among the three common SCFAs has anti-inflammatory properties in ECs, which may be attributed to its inhibitory effect on the Nlrp3 inflammasome formation and activation in these cells.
Since SCFAs are generally considered to have beneficial effects on cardiovascular disease, we are particularly interested in the mechanism mediating the inhibitory effects of butyrate on Nlrp3 inflammasome formation and activation. Given that the LR redox signaling platforms were involved in Nlrp3 inflammasome activation [47, 77] , we determined the contribution of LR redox signaling platform formation and activation induced by 7-Ket and CHC. It was found that butyrate attenuated LR clustering with gp91 or p47 indicating reduction of LR redox signaling platform formation. Direct analysis of O 2
•production in these ECs by DHE staining and ESR spectrometry showed that butyrate blocked 7-Ket or CHC-induced O 2 •production. It seems that butyrate possesses antioxidant action in ECs which may block Nrlp3 inflammasome activation via its redox regulatory domains, such as Nrlp3 binding site to thioredoxin-interacting protein (TXNIP) that is sensitive to redox molecules [78, 79] . In previous studies, the activation of the Nlrp3 inflammasome by increased ROS has been reported in different cells [80] [81] [82] , and NOX and mitochondria-derived ROS may exert an important role [66, 82, 83] . There is evidence that TXNIP was strongly induced by sodium butyrate and thereby increase caspase 3/7 activation, which may be associated with changes in cell redox status [84] . In addition, butyrate has also been reported to increase the expression of catalase mRNA and proteins in colon epithelium [85] and to protect rat pulmonary artery smooth muscle cells from hypoxia by increasing catalase activity [86] . Taken together, it is possible that butyrate exerts its anti-inflammatory action by inhibition of Nlrp3 inflammasome activation via redox signaling pathway, but it may also work to regulate other cell functions via upregulation of antioxidant enzyme expression and activities such as catalase.
In conclusion, we revealed that SCFAs have differential effects on endothelial Nlrp3 inflammasome activation and associated carotid neointima formation in the arterial wall. Butyrate may have beneficial effects against vascular inflammation or atherosclerosis by its inhibitory action on O 2
•production and consequent Nlrp3 inflammasome formation and activation.
